Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide

Journal of Clinical Pathology

Volumn 67, Issue 3, 2014, Pages 251-257

  Figura, Natale ^a   Palazzuoli, Alberto ^a   Vaira, Dino ^b   Campagna, Mariastella ^a   Moretti, Elena ^c   Iacoponi, Francesca ^c   Giordano, Nicola ^a   Clemente, Salvatore ^a   Nuti, Ranuccio ^a   Ponzetto, Antonio ^d  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CYTOKINES; HEART; HELICOBACTER PYLORI;

ACUTE DISEASE; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNORADIOMETRIC ASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; MOLECULAR MIMICRY; NATRIURETIC PEPTIDE, BRAIN; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894284577     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201743     Document Type: Article

References (43)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8. (Pubitemid 28366422)
2. Clerico A, Iervasi G, Pilo A. Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations. Curr Drug Metab 2000;1:85-105.
3. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203. (Pubitemid 24203680)
4. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9. (Pubitemid 23040916)
5. Luchner A, Burnett JC, Jougasaki M, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000;18:1121-8.
6. Cheung BMY, Kumana CR. Natriuretic peptides-relevance in cardiovascular disease. JAMA 1998;280:1983-4.
7. Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma levels of brain natriuretic peptide and myocardial infarct size. Cardiology 1994;85:334-0.
8. Darbar D, Davidson NC, Gillespie N, et al. Diagnostic value of B-type natriuretic peptide concentration in patients with acute myocardial infarction. Am J Cardiol 1996;78:284-7. (Pubitemid 26265268)
9. Arakawa N, Nakamura M, Aoki H, et al. Plasma brain natriuretic peptide concentration predicts survival after acute MI. J Am Coll Cardiol 1996;27:1656-61. (Pubitemid 26198017)
10. Palazzuoli A, Poldermans D, Capobianco S, et al. Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization. Coron Artery Dis 2006;17:419-23. (Pubitemid 44309781)
11. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-8.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
13. van Minkelen R, Wettinger SB, de Visser MC, et al. Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 2009;203:201-5.
14. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72. (Pubitemid 30213096)
15. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615-25. (Pubitemid 19038537)
16. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993;22:89-104. (Pubitemid 23123007)
17. Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
18. Graham DY, Osato MS, Olson CA, et al. Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestation of H. pylori infection. Helicobacter 1998;3:174-8. (Pubitemid 128656483)
19. Yamaoka Y, Kwon DH, Graham DY. A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000;97:7533-8. (Pubitemid 30431498)
20. Yoshida N, Granger DN, Evans DJ Jr, et al. Mechanisms involved in Helicobacter pylori induced inflammation. Gastroenterology 1993;105:1431-40. (Pubitemid 23315318)
21. Kurose I, Granger DN, Evans DJ Jr, et al. Helicobacter pylori induced microvascular protein leakage in rats: role of neutrophils, mastcells and platelets. Gastroenterology 1994;107:70-9.
22. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9. (Pubitemid 2068912)
23. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000;101:1647-52. (Pubitemid 30196623)
24. Mayr M, Kiechl S, Mendall MA, et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003;34:610-5. (Pubitemid 36307380)
25. Gunn M, Stephens JC, Thompson JR, et al. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000;84:267-71.
26. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998;64:104-7. (Pubitemid 28156546)
27. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:739-45. (Pubitemid 23326552)
28. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes a type I-specific and disease-associated virulence factor. Proc Natl Acad Sci USA 1996;93:14648-53.
29. Franceschi F, Sepulveda AR, Gasbarrini A, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002;106:430-4. (Pubitemid 34803686)
30. Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402. (Pubitemid 27359211)
31. Tanaka T, Kanda T, Takahashi T, et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic Peptides mRNA in cultured rat ventricular myocytes. J Intern Med Res 2004;32:57-61. (Pubitemid 38159231)
32. Tanner H, Mohacsi P, Fuller-Bicer GA, et al. Cytokine activation and disease progression in patients with stable and moderate chronic heart failure. J Heart Lung Transplant 2007;26:622-9. (Pubitemid 46818035)
33. Miettinen KH, Lassus J, Harjola V-P, et al. Prognostic role of pro-and anti-inflammatory cytokines and their polymorphism in acute decompensated heart failure. Eur J Heart Fail 2008;10:396-403.
34. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008;5:e78.
35. Picciotto S, Forastiere F, Pistelli R, et al. Determinants of plasma interleukin-6 levels among survivors of myocardial infarction. Eur J Cardiovasc Prev Rehabil 2008;15:631-8.
36. Dighiero G, Lymberi P, Monod C, et al. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol 1990;82:52-6. (Pubitemid 20329237)
37. Das KM, Dasgupta A, Mandal A, et al. Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. J Immunol 1993;150:2487-93. (Pubitemid 23127495)
38. Ebert EC, Geng X, Bajpai M, et al. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis. Am J Gastroenterol 2009;104:2996-3003.
39. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205. (Pubitemid 34059525)
40. Mackiewicz U, Maczewski M, Konior A, et al. Sarcolemmal Ca2+-ATPase ability to transport Ca2+gradually diminishes after myocardial infarction in the rat. Cardiovasc Res 2009;81:546-54.
41. Taylor PV, Scott JS, Gerlis LM, et al. Maternal antibodies against cardiac antigens in congenital complete heart block. N Engl J Med 1986;315:667-72. (Pubitemid 16055932)
42. Horsfall AC, Venables PJ, Taylor PV, et al. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991;4:165-76.
43. Caforio AL, Goldman JH, Haven AJ, et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy. Int J Cardiol 1996;54:157-63. (Pubitemid 26188302)